In addition, while Pcbp1 is unchanged and Pcbp2 is borderline increased, Ncoa4 is significantly increased in bone marrow stem and progenitor cells from MDS patients (Figure 9F–H), enabling increased ferritin degradation in MDS erythroblasts. This evidence concerns the gene NCOA4 and myelodysplastic syndrome.